← Back to Search

Behavioral Activation for Anhedonia

N/A
Waitlist Available
Led By Gabriel S Dichter, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 15 weeks
Awards & highlights

Study Summary

This trial will develop a new treatment for anhedonia, and use brain imaging to study how it impacts the systems that control rewards and symptoms.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 15 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 15 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline to Week 15 in Snaith-Hamilton Pleasure Scale Score
Secondary outcome measures
Change from Baseline to Week 15 in Neural Activation

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral ActivationExperimental Treatment1 Intervention
Treatment will consist of 15 weekly 45-minute sessions. Session 1 provides orientation and psychoeducation on anhedonia, and activity monitoring is introduced. Sessions 2-3 include structured values assessments of 10 life areas to enhance motivation for sustained behavior change and to clarify goals. Following goals clarification, an activity hierarchy is developed, establishing a set of idiographic behavioral targets across life areas prioritized by ease of implementation to scaffold task engagement during the course of treatment.
Group II: Mindfulness TreatmentActive Control1 Intervention
BATA will be compared to mindfulness based cognitive therapy (MBCT), chosen because its mechanisms of action are hypothesized to impact different brain mechanisms than BATA. Mindfulness is nonjudgmentally bringing awareness and acceptance to one's present-moment experience. MBCT will be administered in an individual format. The MBCT protocol will be modeled on the session outlines presented in Wahbeh et al., 2014. Treatment will be compromised of 15 weekly 45-minute sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Activation
2013
Completed Phase 3
~2980

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,504 Previous Clinical Trials
4,187,546 Total Patients Enrolled
3 Trials studying Anhedonia
229 Patients Enrolled for Anhedonia
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,688,991 Total Patients Enrolled
17 Trials studying Anhedonia
1,760 Patients Enrolled for Anhedonia
Duke UniversityOTHER
2,358 Previous Clinical Trials
3,419,953 Total Patients Enrolled
1 Trials studying Anhedonia
57 Patients Enrolled for Anhedonia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom is enrolment to this experiment accessible?

"This medical trial seeks 150 individuals aged 18-50 with clinically significant anhedonia, as indicated by a SHAPS score of at least 20. Additionally, participants must have already sought treatment for their condition or responded to an advertisement seeking treatment and be rated 3 or higher on the CGI-S rating scale."

Answered by AI

Are octogenarians eligible to apply for this research?

"The minimum age for this medical trial is 18 years old and the maximum age permissible is 50. There are, however, seperate trials available to those under the legal limit of majority as well as those past retirement age."

Answered by AI

What is the current capacity of participants in this medical experiment?

"Affirmative. Clinicaltrials.gov provides evidence that this clinical study, first posted on August 1st 2019, is actively recruiting volunteers. The medical experiment seeks 150 people from a single location."

Answered by AI

Are there any openings remaining for participants in this research?

"Per the information on clinicaltrials.gov, this research is seeking to enrol participants. The trial was initially advertised in August of 2019 and recently refreshed its details as of August 9th 2022."

Answered by AI

Who else is applying?

What state do they live in?
Missouri
How old are they?
18 - 65
What portion of applicants met pre-screening criteria?
Did not meet criteria
Recent research and studies
clinicaltrials.govStudy
Development of a Novel Transdiagnostic Intervention for Anhedonia - R33 Phase
2019. "Development of a Novel Transdiagnostic Intervention for Anhedonia - R33 Phase". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04036136.
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top